The Recall Desk
Severity pendingFDA (Devices)·Z-2323-2025·Announced 2025-08-20

HemosIL LMW Heparin Controls; Part Number: 0020300200;

Pending LLM rewrite. Source: FDA_DEVICE Z-2323-2025.

Severity not yet assessed

We have not scored this recall against our rubric yet, so we are not showing a severity rating or our usual guidance. The agency’s own notice below is the authoritative source — read it first.

Plain-English summary

Multiple complaints indicating lower than expected quality control (QC) results and in some instances QC recovery below the lower limit of the package insert acceptance range when testing is performed with HemosIL Liquid Anti-Xa and HemosIL Heparin Calibrator. In some complaints, failure to pass QC resulted in patient testing delays.

The recalled product

Product
HemosIL LMW Heparin Controls; Part Number: 0020300200;
Manufacturer
Instrumentation Laboratory

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (11)

  • Part Number: 0020300200
  • UDI-DI: 08426950472490
  • Lot Numbers: N0330228
  • N0632773
  • N0935135
  • N1036592
  • N0148986
  • N0441476
  • N0643673
  • N0845161
  • N1147397

Distribution

Distributed nationwide across the United States.